MedPath

Inspiratory Muscle Training in Patients With Autonomic Neuropathic

Phase 4
Conditions
Diabetes Mellitus
Diabetic Autonomic Neuropathy
Registration Number
NCT00752440
Lead Sponsor
Instituto de Cardiologia do Rio Grande do Sul
Brief Summary

This study describes a controlled randomized clinical trial to evaluate the effect of inspiratory muscle training in patients with diabetic autonomic neuropathy.

Detailed Description

The diabetic autonomic neuropathy (NAD) is a common complication of diabetes mellitus (DM), both of the type 1 diabetes mellitus (DM1) as of the type 2 diabetes mellitus (DM2). The results of this study, would help to reveal the degree of commitment generated by NAD in respiratory muscle strength, can also enable the development of a new therapeutic approach, such non-pharmacological (respiratory muscle training), with a view to improve the respiratory muscle strength and alleviate the autonomic dysfunction in these patients.

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
24
Inclusion Criteria
  • Diabetic autonomic neuropathy
  • Age between 36 and
  • 70 years old and signed in informed consent form
Exclusion Criteria
  • Presence of congestive heart failure
  • Chronic obstructive pulmonary disease (FEV1 < 70% and/or FEV1%< 80
  • Class II or III obesity (body mass index > 35)

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Primary Outcome Measures
NameTimeMethod
Inspiratory muscle strengtheight
Secondary Outcome Measures
NameTimeMethod
Variability of heart rateeight

Trial Locations

Locations (1)

Institudo de Cardiologia do Rio Grande do Sul

🇧🇷

Porto Alegre, RGS, Brazil

© Copyright 2025. All Rights Reserved by MedPath